Zobrazeno 1 - 10
of 766
pro vyhledávání: '"Yao Chun Hsu"'
Autor:
Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 375-387 (2024)
Background/Aims Oral EDP-514 is a potent core protein inhibitor of hepatitis B virus (HBV) replication, which produced a >4-log viral load reduction in HBV-infected chimeric mice with human liver cells. This study evaluated the safety, pharmacokineti
Externí odkaz:
https://doaj.org/article/ed2aee832b8041db91c2040ffaf8a503
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 2, Pp 293-296 (2024)
Externí odkaz:
https://doaj.org/article/3093d219d79f486aa93953a0cf4d0a8c
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 2, Pp 276-278 (2024)
Externí odkaz:
https://doaj.org/article/839ad85521494bd197ec53005c48a421
Autor:
Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, Tzu-Haw Chen, Yi-Ling Wu, Chieh-Chang Chen, Yu-Jen Fang, Tzeng-Huey Yang, Mindie H. Nguyen, Jaw-Town Lin, Yao-Chun Hsu
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 1, Pp 98-108 (2024)
Background/Aims Finite nucleos(t)ide analog (NA) therapy has been proposed as an alternative treatment strategy for chronic hepatitis B (CHB), but biomarkers for post-treatment monitoring are limited. We investigated whether measuring hepatitis B cor
Externí odkaz:
https://doaj.org/article/e6cca0a680c349dfb2095f17e98b207d
Autor:
Huang, Hsuan-Yu, Chen, Chia-Hung, Cheng, Fang-Ju, Wang, Bo-Wei, Tu, Chih-Yen, Chen, Yun-Ju, He, Yu-Hao, Yao, Chun-Hsu, Huang, Wei-Chien
Publikováno v:
In Journal of Hazardous Materials 15 September 2024 477
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 4, Pp 869-890 (2023)
Nucleos(t)ide analogues (NA) are widely used to treat hepatitis B virus (HBV) infection, but they cannot eradicate the virus and treatment duration can be lifelong if the endpoint is set at seroclearance of the hepatitis B surface antigen (HBsAg). As
Externí odkaz:
https://doaj.org/article/e4d2c47c3a014b8aab83c69b44b79437
Autor:
Yao, Chun-Hsu, Shen, Zhao-Qing, Rajan, Yesudoss Christu, Huang, Yu-Wen, Lin, Chin-Yu, Song, Jen-Shin, Shiao, Hui-Yi, Ke, Yi-Yu, Fan, Yu-Shiou, Tsai, Chi-Hui, Yeh, Teng-Kuang, Tsai, Ting-Fen, Lee, Jinq-Chyi
Publikováno v:
In European Journal of Medicinal Chemistry 5 October 2023 258
Autor:
Fang, Jui, Liu, Yi-Wen, Chen, Yi-Wen, Shih, Tzu-Ching, Yao, Chun-Hsu, Tsai, Chon-Haw, Tyler, Richard S., Hsu, Alan, Wang, Tang-Chuan
Publikováno v:
In Applied Acoustics September 2023 212
Autor:
Nguyen, Duc Dung, Yao, Chun-Hsu, Lue, Shingjiang Jessie, Yang, Chia-Jung, Su, Yun-Han, Huang, Chih-Ching, Lai, Jui-Yang
Publikováno v:
In Chemical Engineering Journal 1 January 2023 451 Part 1
Autor:
Ya‐Chin Wang, Ming‐Chao Tsai, Yaw‐Sen Chen, Pei‐Min Hsieh, Chao‐Ming Hung, Hung‐Yu Lin, Yao‐Chun Hsu, Jen‐Hao Yeh, Pojen Hsiao, Yu‐Cheih Su, Ching‐Hou Ma, Chih‐Yuan Lee, Chih‐Che Lin, Chih‐Wen Shu, Yu‐Chan Li, Mei‐Hsing Tsai, James Yu Lin, Wei‐Hao Peng, Ming‐Lung Yu, Chih‐Wen Lin
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3563-3577 (2022)
Abstract Hepatocellular carcinoma (HCC) is a highly invasive malignancy. Recently, GATOR1 (Gap Activity TOward Rags 1) complexes have been shown to play an important role in regulating tumor growth. NPRL2 is a critical component of the GATOR1 complex
Externí odkaz:
https://doaj.org/article/570acea9db984957a14221e692b0d8b3